Unified Laboratory Intelligence for Impurity Resolution Management
White Paper Nov 18, 2013
Maximizing the effective patent life of a marketed drug is one of the main priorities for researchers. According to a March 2010 article in Nature, the estimated average cost for pharmaceutical companies to bring a new chemical entity (NCE) to market is approximately 1.8 billion and requires 13.5 years on average. Identifying and characterizing an impurity in a couple of days less time can literally equate to a gain of a million dollars in net present value. Being able to do this repeatedly as impurities are encountered through the drug development and acceptance of a drug substance can shave weeks, or even months, off the time to market, increasing returns by millions of dollars.
Unified Laboratory Intelligence (ULI) is a category of R&D informatics that combines software, algorithmic tools, and databases to form a scalable platform for the collection and unification of chemical, structural, and analytical data. ULI accumulates information and knowledge from successive projects across different chemistry disciplines to create a one-to-many chemical intelligence-from-information ‘live’ cycle. With ULI, scientists can easily search and quickly retrieve ‘live’ data to gain and apply intelligence and insight that improves decision-making.
Related White Papers
A Comparison Between PCA and Hierarchical ClusteringWhite Paper
Graphical representations of high-dimensional data sets are at the backbone of straightforward exploratory analysis and hypothesis generation. Within the life sciences, two of the most commonly used methods for this purpose are heatmaps combined with hierarchical clustering and principal component analysis (PCA).READ MORE
Ten Ways to…..Control Rheology by Changing Particle Properties (Size, Zeta Potential and Shape)White Paper
Malvern Instruments LimitedREAD MORE